Hemoglobin A1c in Diabetes: Panacea or Pointless?
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Glycation is the nonenzymatic attachment ofa monosaccharide to amino groups of proteins.The reaction has been recognized for manyyears in the food industry, where it is known as browning (also termed the Maillard reaction) and is re-sponsible for the formation of commonly ingested items, such as toast. In patients with diabetes, glucose accumu-lation results in enhanced glycation of many proteins, both in tissues (e.g., the lens) and in the blood. Of these, glycated hemoglobin (GHb) is by far the most frequently measured in patient care. Hemoglobin (Hb) in healthy adults consists predominantly of HbA, which has 2a- and 2b-chains. Glucose can attach to several amino acid resi-dues in these chains. HbA1c is formed when glucose attaches specifically to the NH2-terminal valine of the b-chain. Formation of HbA1c is essentially irreversible, and its concentration in the blood depends on both the life span of the red blood cell (RBC), which averages w120 days, and the blood glucose concentration. Because the rate of formation of HbA1c is directly proportional to the concentration of glucose in the blood, HbA1c represents integrated values for glucose over the preceding 8 to 12 weeks (Table 1). CLINICAL VALUE OF HbA1c Initially described 57 years ago (1), GHb was first reported to be increased in patients with diabetes in the late 1960s (2). The clinical value of GHb was soon realized and the American Diabetes Association (ADA) began encouraging the routine measurement of GHb in all patients with di-abetes (3). The fundamental role of GHb in diabetes was accentu-ated by the publication in 1993 of the Diabetes Control and Complications Trial (DCCT) (4). The study, which compared intensive to conventional insulin therapy in patients with type 1 diabetes, documented a direct relation-ship between blood glucose concentrations (assessed by HbA1c) and the risk of microvascular complications. The absolute risks of retinopathy and nephropathy were di-rectly proportional to the mean HbA1c concentration. (To prevent assay variability [see “Development of Accurate HbA1c Measurements ” below], all GHb assays in the DCCT were performed in a single laboratory that measured
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Hoelzel, W., Weykamp, C., Jeppsson, J.-O., Miedema, K., Barr, J. R., Goodall, I., Hoshino, T., John, W. G., Kobold, U., Little, R., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.024802 · Cited by 690
Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin
Bry, L., Chen, P. C., & Sacks, D. B. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.2.153 · Cited by 523 · cited 1×
“The effects of hemoglobin variants (such as HbS, HbE, HbD, and HbC) are contingent upon the specific method of analysis used (17).”
MethodSelf-citationLittle, R. R., Rohlfing, C. L., & Sacks, D. B. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.148841 · Cited by 365
Self-citationClinical impact of glycated albumin as another glycemic control marker
Koga, M., & Kasayama, S. (2010) · Endocrine Journal · doi:10.1507/endocrj.k10e-138 · Cited by 290 · cited 1×
“A test for glycated albumin alone has also been developed (26).”
BackgroundEffects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus
Tarim, O., Kucukerdogan, A., Gunay, U., Eralp, O., & Ercan, I. (1999) · Pediatrics International · doi:10.1046/j.1442-200x.1999.t01-1-01083.x · Cited by 198
Racial differences in glycemic markers: a cross-sectional analysis of community-based data
Selvin, E., Steffes, M. W., Ballantyne, C. M., Hoogeveen, R. C., Coresh, J., & Brancati, F. L. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-5-201103010-00004 · Cited by 196 · cited 1×
“Some authors posit that the increased HbA1c accurately reflects higher glucose values in these populations (15).”
BackgroundDistribution of HbA1c Levels For Children and Young Adults in the U.S.
Saaddine, J. B., Fagot-Campagna, A., Rolka, D., Narayan, K. M. V., Geiss, L., Eberhardt, M., & Flegal, K. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1326 · Cited by 177
Berg, A. H., & Sacks, D. B. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.049205 · Cited by 41 · cited 2×
“1%) in a sample analyzed by two different methods (9).”
MethodSelf-citation
Cited by
Bergenstal, R. M., Ahmann, A. J., Bailey, T., Beck, R. W., Bissen, J., Buckingham, B., Deeb, L., Dolin, R. H., Garg, S. K., Goland, R., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0051 · Cited by 307
Selvin, E., Rawlings, A. M., Grams, M., Klein, R., Sharrett, A. R., Steffes, M., & Coresh, J. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70199-2 · Cited by 262
Wright, L. A.-C., & Hirsch, I. B. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0029 · Cited by 178
“Conditions that affect red blood cell (RBC) life span will impact its value, independent of glycemia.(5) The degree of such impact is currently immeasurable and frequently not fully appreciated.”
BackgroundParrinello, C. M., & Selvin, E. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0548-3 · Cited by 154
Malka, R., Nathan, D. M., & Higgins, J. M. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9304 · Cited by 134
Selvin, E. (2016) · Diabetes Care · doi:10.2337/dc16-0042 · Cited by 96
Update on biomarkers of glycemic control
Krhač, M., & Lovrenčić, M. V. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i1.1 · Cited by 93
Metadata
- Authors
- Sacks, D. B.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-12-13
- Volume
- 62
- Issue
- 1
- Pages
- 41-43
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2153938957
- Cited by
- 54
- References
- 11
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.